Abstract:Background: Hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) is characterized by high chemotherapy resistance; however, the underlying mechanism has not been fully clarified. In addition, HBx protein has been reported to play a key role in virus-mediated hepatocarcinogenesis. Therefore, the present study aims to investigate the role of HBx in the drug-resistance of HBV-related HCC and examine whether such drug-resistance can be reversed by IFN-alpha treatment.Methods: We established HBx-expressing cells by liposome-mediated transfection of HBx into the Huh7 cell line. MTT, Annexin V/PI, and cell cycle assay were used for determining the cellular growth inhibition, apoptosis, and growth arrest, respectively, after treatment with chemical drug. We further used tumor-bearing mice model to compare the tumor growth inhibition efficacy of ADM and 5-FU between the Huh7-HBx group and the control group, as well as the ADM + IFN-alpha or ADM + IMD treated group and the ADM treated group. SQ-Real time-PCR was performed to analyze the expression of MDR-associated genes and anti-apoptotic genes. Moreover, immunofluorescence and Western blotting were used to determine the subcellular localization of p65 and the phosphorylation of I kappa B alpha.Results: The IC50 values of Huh7-HBx cells against ADM and Amn were 2.317 and 1.828-folds higher than those of Huh7-3.1 cells, respectively. The apoptosis ratio and growth arrest was significantly lower in Huh7-HBx cells after treatment with ADM. The in vivo experiment also confirmed that the Huh7-HBx group was much more resistant to ADM or 5-FU than the control. Furthermore, the expression of MDR-associated genes, such as MDR1, MRP1, LRP1, and ABCG2, were significantly up-regulated in Huh7-HBx cells, and the NF-kappa B pathway was activated after HBx gene transfection in Huh7 cells. However, combined with IFN-alpha in ADM treatment, the HBx induced drug-resistance in Huh7-HBx cells can be partly abolished in in vitro and in vivo models. Moreover, we found that the NF-kappa B canonical pathway was affected by IFN-alpha treatment, and the expression of anti-apoptotic genes, such as Gadd45 beta, Survivin, and c-IAP-1 was down-regulated by IFN-alpha treatment in a dose-dependent manner.Conclusions: HBx protein can induce MDR of HBV-related HCC by activating the NF-kappa B pathway, which can be partly abolished by IFN-alpha treatment.

Cross-talk Between TNF-α and IFN-γ Signaling in Induction of B7-H1 Expression in Hepatocellular Carcinoma Cells

Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas

Functional Expression of B7H1 on Pancreatic Carcinoma Panc-1 Cells

Distinct Role of Interleukin-6 and Tumor Necrosis Factor Receptor-1 in Oval Cell- Mediated Liver Regeneration and Inflammation-Associated Hepatocarcinogenesis

Expression of TIGIT/CD155 and Correlations with Clinical Pathological Features in Human Hepatocellular Carcinoma

Interleukin-17A facilitates tumor progression via upregulating programmed death ligand-1 expression in hepatocellular carcinoma

B7-H1 Up-Regulated Expression in Human Hepatocellular Carcinoma Tissue: Correlation with Tumor Interleukin-10 Levels.

Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3

Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells

Upregulation of B7-H4 Promotes Tumor Progression of Intrahepatic Cholangiocarcinoma

Stimulation of B7-H1 in Hepatocarcinoma Cells by Hepatitis B Virus X Antigen.

Expression of B7-H6 Expression in Human Hepatocellular Carcinoma and Its Clinical Significance

Interaction of B7-H1 on Intrahepatic Cholangiocarcinoma Cells with Pd-1 on Tumor-Infiltrating T Cells As A Mechanism of Immune Evasion

MYC Inhibition Increases PD-L1 Expression Induced by IFN-γ in Hepatocellular Carcinoma Cells.

Interferon-a potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment

Interferon-α Sensitizes HBx-expressing Hepatocarcinoma Cells to Chemotherapeutic Drugs Through Inhibition of HBx-mediated NF-κB Activation

TNF-alpha promotes cell cycle progression by activating NF-kappa B signal pathway in hepatic cell line L-02

Triple Expression of B7-1, B7-2 and 4-1BBL Enhanced Antitumor Immune Response Against Mouse H22 Hepatocellular Carcinoma

Hepatoma Cell-Intrinsic TLR9 Activation Induces Immune Escape Through PD-L1 Upregulation in Hepatocellular Carcinoma

Effect of Regulatory B Cell Expansion on Tissue-Resident TPH Cells Immune Evasion in Hepatocellular Carcinoma.

Type I IFNs repolarized a CD169+ macrophage population with anti-tumor potentials in hepatocellular carcinoma